According to the UnivDatos, the increasing prevalence of chronic diseases, the growing elderly population, and advancements in medical technology will drive the scenario of the Indian catheter market. As per their “India Catheters Market” report, the market was valued at ~USD 851 million in 2023, growing at a CAGR of about 17.2% during the forecast period from 2024-2032 to reach USD million by 2032.

The Indian catheter market has witnessed several new product introductions in the last few years since the manufacturers strive to work on problems related to patient care,

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/india-catheter-market?popup=report-enquiry

 DRUG-ELUTING CATHETERS

These catheters are meant to administer certain medications at a specific site or the general circulation of the body. They help in dispensing with other problems such as the formation of blood clots and hence infections. Drug-coated catheters are reported to be incorporated into cardiovascular operations because of the gains in patients’ results accompanied by less invasive additional procedures.

SMART CATHETERS

Connected catheters contain sensors and can be connected to other devices and applications; they allow continuous monitoring of physiological characteristics of patients’ state. These innovations make it easier for clinicians to track catheter performance and other clinical parameters that affect decision making; inflammation is less likely to happen.

BIOENGINEERED CATHETERS

The materials used are biocompatible and bioresorbable, and there are few complications with the body and better tissue incorporation. Such catheters serve to minimize the possibility of an infection and to improve the likely outcome in patients diagnosed with chronic disease.

CATHETERS COATED WITH ANTIMICROBIALS

These catheters have what the microbes cannot attach themselves to the catheters hence reducing instances of catheter-associated complications to a great extent. Implementing antimicrobial coatings has been associated with fewer incidences of hospital-acquired infections apart from the normal costs associated with patient safety.

MINIMALLY INVASIVE CATHETERS

A catalog of changes has inclined new inventiveness with respect to the catheters that endorse less invasive measures and methods that are carried out by interventional cardiologists and radiologists. They also propose that these catheters shorten patient recovery periods post-surgery, lessen the occurrence of complications after operations, and enhance general procedure efficacy.

CUSTOMIZED CATHETERS

Currently, some manufacturers are focusing on self-designing catheters according to the needs of patients including length, diameter, and material. This means that when the implantable devices are made to fit individual patients, there is a great level of comfort obtained when using the devices.

CLOSED-SUCTION CATHETERS

Intended for the reduction of contact with pathogens during suctioning, these catheters are applied in respiratory therapy to remove secretions. Ventilator circuits make the patient comfortable, safe, and free from VAP since they help to minimize the risks associated with closed-suction systems.

RADIOPAQUE CATHETERS

These catheters have incorporated some materials that can be seen through imaging during the procedure. These catheters provide better visual reference during placement and do not require re-positioning which leads to re-imaging and increased patient radiation dosage.

PEDIATRIC FOLEY CATHETERS

Catheters have been designed to meet the needs of the pediatric population, in terms of size and utility. They cite these catheters to enhance security and effectiveness in pediatric practice, given the distinctiveness of this population.

SINGLE-USE CATHETERS

Several developments have brought into the market catheters that are single-use or pre-packed thereby minimizing instances of cross infections. Various medical procedures that apply catheters require their single-use to minimize procedures associated with related infections.

Recent Developments in the market are:

In July 2024, Hyderabad-based startup Mexple, a leader in innovative personal medical products, announced the launch of its groundbreaking UroMen and UroWomen urine collection kits for males and females in the incontinence category with external urinary catheters.

In February 2023, Coloplast launched a male catheter designed to reduce the risk of urinary tract infections. The new intermittent catheter LujaTM addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole.

Click here to view the Report Description & TOC : https://univdatos.com/reports/india-catheter-market

Conclusion

The advancements in the Indian catheter market are characterized by the pursuit of better patient outcomes, better procedural outcomes, and better concern for the patient demographic. With the increased use of technology, these solutions should help spur future development in the field while also improving overall healthcare.

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/